China Pharma Holdings (CPHI) Free Cash Flow (2010 - 2026)

China Pharma Holdings (CPHI) has reported Free Cash Flow for 17 consecutive years, with -$32828.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 111.96% year-over-year to -$32828.0; the trailing twelve-month figure through Jun 2026 stood at -$141555.0 (down 136.88% YoY), and the FY2025 full-year result was $88937.0, up 120.01% from the prior year.
• Free Cash Flow improved to -$32828.0 in Q2 2026 per CPHI's latest filing, from -$55292.0 in the prior quarter.
• Across five years, Free Cash Flow topped out at $939831.0 in Q3 2023 and bottomed at -$1.4 million in Q1 2023.
• Historically, Free Cash Flow has averaged -$107682.4 across 5 years, with a median of -$46512.0 in 2024.
• The sharpest annual moves came in 2023 and 2025: Free Cash Flow soared 2911.59% in 2023, then slumped 443.23% in 2025.
• Over 5 years, Free Cash Flow stood at $611862.0 in 2022, then plunged by 104.39% to -$26850.0 in 2023, then soared by 1139.96% to $279228.0 in 2024, then tumbled by 45.73% to $151536.0 in 2025, then slumped by 121.66% to -$32828.0 in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$32828.0, -$55292.0, and $151536.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.